Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Nature Medicine|November 10, 2009
Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotypeDaniel T Starczynowski, Florian Kuchenbauer, Bob Argiropoulos, et al.
Blood Advances|May 19, 2023
Repression of TRIM13 by chromatin assembly factor CHAF1B is critical for AML developmentSarai T Dean, Chiharu Ishikawa, Xiaoqin Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2025
Optimization of IRAK1/4/pan-FLT3 kinase inhibitors as treatments for acute myeloid leukemiaPatrick J Sutter, Morgan M Walker, Chris J Finocchio, et al.
The Journal of Clinical Investigation|May 15, 2025
Ubiquitin-conjugating enzyme UBE2N modulates proteostasis in immunoproteasome-positive acute myeloid leukemiaChiharu Ishikawa, Laura Barreyro, Avery M Sampson, et al.
Cell Stem Cell|September 2, 2021
Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasiaTimothy M Chlon, Emily Stepanchick, Courtney E Hershberger, et al.
Oncotarget|November 4, 2015
IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survivalAllie K Adams, Lyndsey C Bolanos, Phillip J Dexheimer, et al.
Leukemia|April 12, 2024
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progressionShinichiro Matsui, Chihiro Ri, Lyndsey C Bolanos, et al.
Blood Advances|October 3, 2018
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in miceYue Wei, Hong Zheng, Naran Bao, et al.
Pageof 9